Carousel Capital has suspended the sale process for Palmetto Infusion Services, multiple sources tell Axios.
Why it matters: While investors are eager to build out ambulatory infusion center networks to disrupt a market historically dominated by hospitals, this Southeast-centric player is punting sale plans to a future date.
